Copyright
©The Author(s) 2022.
World J Pharmacol. Jan 28, 2022; 11(1): 1-5
Published online Jan 28, 2022. doi: 10.5497/wjp.v11.i1.1
Published online Jan 28, 2022. doi: 10.5497/wjp.v11.i1.1
Figure 1 Activation of the mammalian target of rapamycin pathway in intestinal epithelial cells has been shown to induce inflammation.
TNF: Tumor necrosis factor; IL: Interleukin; IFN: Interferon; IGF: Insulin-like growth factor; EGFR: Epidermal growth factor receptor; mTOR: Mammalian target of rapamycin.
- Citation: Lashgari NA, Roudsari NM, Momtaz S, Abdolghaffari AH. Mammalian target of rapamycin-novel insight for management of inflammatory bowel diseases. World J Pharmacol 2022; 11(1): 1-5
- URL: https://www.wjgnet.com/2220-3192/full/v11/i1/1.htm
- DOI: https://dx.doi.org/10.5497/wjp.v11.i1.1